4//SEC Filing
Gilbert Halley E 4
Accession 0001601360-25-000007
CIK 0001787306other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 6:21 PM ET
Size
9.0 KB
Accession
0001601360-25-000007
Insider Transaction Report
Form 4
Gilbert Halley E
Director
Transactions
- Sale
Common Stock
2025-11-20$27.55/sh−16,532$455,442→ 22,123 total - Exercise/Conversion
Stock Option (right to buy)
2025-11-20−12,220→ 0 totalExercise: $7.51Exp: 2033-05-31→ Common Stock (12,220 underlying) - Exercise/Conversion
Common Stock
2025-11-20$7.51/sh+12,220$91,772→ 38,655 total
Footnotes (2)
- [F1]The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $27.32 to $27.72, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001601360
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 6:21 PM ET
- Size
- 9.0 KB